Showing results (101-110 of 137) with videos related to
Sort By:
Pageof 14
JAMA Network Open|June 10, 2024
Stereotactic Body Radiotherapy and Liver Transplant for Liver Cancer: A Nonrandomized Controlled TrialVictor Ho-Fun Lee, Varut Vardhanabhuti, Tiffany Cho-Lam Wong, et al.Life (Basel, Switzerland)|February 25, 2022
A Multi-Center Study of CT-Based Neck Nodal Radiomics for Predicting an Adaptive Radiotherapy Trigger of Ill-Fitted Thermoplastic Masks in Patients with Nasopharyngeal CarcinomaSai-Kit Lam, Jiang Zhang, Yuan-Peng Zhang, et al.Clinical and Translational Medicine|December 15, 2025
Tertiary lymphoid structure-related RNA indicator as metastasis risk factor in nasopharyngeal carcinomaZhaozheng Hou, Ping Feng, Chi-Leung Chiang, et al.Oncotarget|December 29, 2016
Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinomaVictor Ho-Fun Lee, Dora Lai-Wan Kwong, To-Wai Leung, et al.International Journal of Cancer|June 7, 2018
Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong ChineseJosephine Mun-Yee Ko, Kay Hiu-Ki Tsang, Wei Dai, et al.Ebiomedicine|November 13, 2022
Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinomaLarry Ka-Yue Chow, Dittman Lai-Shun Chung, Lihua Tao, et al.Gastroenterology|August 25, 2015
Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer CellsValen Zhuoyou Yu, Victor Chun-Lam Wong, Wei Dai, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 8, 2019
Comparing dyadic cognitive behavioral therapy (CBT) with dyadic integrative body-mind-spirit intervention (I-BMS) for Chinese family caregivers of lung cancer patients: a randomized controlled trialDaiming Xiu, Yat-Lui Fung, Bobo Hi-Po Lau, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 2, 2025
First-Line Lorlatinib Versus Crizotinib in Asian Patients With Advanced ALK-Positive NSCLC: Five-Year Outcomes From the CROWN StudyYi-Long Wu, Hye Ryun Kim, Ross A Soo, et al.JTO Clinical and Research Reports|May 24, 2023
Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLCQing Zhou, Ross A Soo, Gee-Chen Chang, et al.Pageof 14